Solutions for Reducing Patient Cost Sharing for Medications

In 2010, clinic Fletcher was diagnosed with chronic lymphocytic leukemia. Within 6 months of starting treatment, check his disease was in remission. But this good news did not last as he relapsed just 9 months later. He began treatment again, but the results were poor: Fletcher developed congested lungs, a persistent cough, and cataracts that left him temporarily blind. So, his doctor proposed a different treatment. Exhausted, but hopeful, Fletcher was ready to try the new drug until he heard what it would cost him—$2310 out of pocket (OOP) for just 1 month of treatment. His best chance of survival would consume nearly his entire month’s take-home pay.

Click here to read more